WASHINGTON — Senior Biden officials are in discussions about what to do with millions of original Covid-19 vaccines after the FDA’s authorization of new, updated shots this week bumped them to the sidelines.
In the coming days, people in the United States and the United Kingdom will be among the first to receive a new breed of COVID-19 vaccine. The hope was that these updated vaccines — based on Omicron variants of the SARS-CoV-2 virus — would offer substantially greater protection than older vaccines based on the strain of the virus that emerged in 2019.
Regulators in China approved a COVID-19 vaccine mist for use as a booster dose, making it the first alternative to injectable vaccines used during the pandemic.
Recent Comments